SPHERA FUNDS MANAGEMENT LTD.
Top Portfolio Positions
92 positions ·
$593,159,262 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| MLYS |
Mineralys Therapeutics, Inc.
Healthcare
|
1,339,971 | $36,299,814 | 6.12% | |
| TEVA |
Teva Pharmaceutical Industries Ltd
Healthcare
|
1,136,975 | $34,245,687 | 5.77% | |
| TSEM |
Tower Semiconductor Ltd
Technology
|
145,735 | $25,573,577 | 4.31% | |
| NVMI |
Nova Ltd.
Technology
|
53,366 | $23,175,786 | 3.91% | |
| CYTK |
Cytokinetics Inc
Healthcare
|
299,117 | $19,714,801 | 3.32% | |
| BBIO |
BridgeBio Pharma, Inc.
Healthcare
|
245,246 | $18,211,967 | 3.07% | |
| BIIB |
Biogen Inc.
Healthcare
|
92,526 | $16,962,791 | 2.86% | |
| RARE |
Ultragenyx Pharmaceutical Inc.
Healthcare
|
809,333 | $16,955,526 | 2.86% | |
| SNDX |
Syndax Pharmaceuticals Inc
Healthcare
|
724,563 | $16,925,791 | 2.85% | |
| COGT |
Cogent Biosciences, Inc.
Healthcare
|
416,340 | $16,024,926 | 2.70% |
Portfolio Trend
25 quarters · across all stocks
Holdings in PHVS
Shares Held
Position Value (USD)
9 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2025-12-31 | $1,774,695 | 63,953 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $2,979,179 | 119,406 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $5,454,785 | 309,931 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $6,026,539 | 383,856 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $7,441,468 | 388,183 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $8,135,687 | 439,292 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $7,581,382 | 403,265 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $9,079,387 | 392,877 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $6,872,250 | 245,000 | Shares | Defined | 2024-02-15 | |
| No 13F history on record for this holder in this stock. | ||||||